Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Greater Baltimore Medical Center Country of Publication: United States NLM ID: 101601396 Publication Model: eCollection Cited Medium: Print ISSN: 2000-9666 (Print) Linking ISSN: 20009666 NLM ISO Abbreviation: J Community Hosp Intern Med Perspect Subsets: PubMed not MEDLINE
    • بيانات النشر:
      Publication: 2022- : Baltimore : Greater Baltimore Medical Center
      Original Publication: Sweden : Co-Action Publ.
    • نبذة مختصرة :
      Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent pericarditis. Corticosteroids are frequently used in patients with recurrent episodes of pericarditis. In patients with corticosteroid dependent and corticosteroid-resistant pericarditis, several steroid-sparing options like azathioprine, intravenous immunoglobulin (IVIG), and anakinra are being recently tried. In this article, we present the case of a 44-year-old male with recurrent pericarditis, who was successfully treated with anakinra. Abbreviations : Non-steroidal anti-inflammatory drugs, NSAIDS; Aspirin, ASA; Erythrocyte sedimentation rate, ESR; Serum Protein Electrophoresis, SPEP; Magnetic Resonance Imaging, MRI; C-Reactive Protein, CRP; Aspartate Aminotransferase, AST; Alanine Aminotransferase, ALT; Idiopathic recurrent pericarditis, IRP; Intravenous Immunoglobulin, IVIG.
      Competing Interests: No potential conflict of interest was reported by the author(s).
      (© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.)
    • References:
      Arch Intern Med. 2005 Sep 26;165(17):1987-91. (PMID: 16186468)
      Eur Heart J. 2015 Nov 7;36(42):2921-2964. (PMID: 26320112)
      JAMA. 2016 Nov 8;316(18):1906-1912. (PMID: 27825009)
      N Engl J Med. 2014 Dec 18;371(25):2410-6. (PMID: 25517707)
      J Pediatr. 2014 Jun;164(6):1425-31.e1. (PMID: 24630353)
      Ann Intern Med. 2011 Oct 4;155(7):409-14. (PMID: 21873705)
      J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):217-30. (PMID: 19262208)
      Arthritis Res Ther. 2011;13(6):R196. (PMID: 22146561)
      Lancet. 2014 Jun 28;383(9936):2232-7. (PMID: 24694983)
      Autoimmun Rev. 2012 Nov;12(1):60-5. (PMID: 22884556)
      Semin Immunol. 2013 Dec 15;25(6):469-84. (PMID: 24275598)
      JAMA. 2015 Oct 13;314(14):1498-506. (PMID: 26461998)
      Eur J Prev Cardiol. 2020 Jun;27(9):956-964. (PMID: 31610707)
      Clin Rev Allergy Immunol. 2013 Feb;44(1):6-13. (PMID: 21170606)
      Am J Cardiol. 2015 Oct 15;116(8):1277-9. (PMID: 26279106)
      Autoimmun Rev. 2019 Jun;18(6):627-631. (PMID: 30959216)
    • Contributed Indexing:
      Keywords: Anakinra; interleukin-1 inhibitor; recurrent pericarditis
    • الموضوع:
      Date Created: 20210715 Latest Revision: 20210716
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC8262628
    • الرقم المعرف:
      10.1080/20009666.2021.1933716
    • الرقم المعرف:
      34262672